RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kaken Pharmaceutical Co Stock

Kaken Pharmaceutical Co P/S 2024

Kaken Pharmaceutical Co P/S

1.98

Ticker

4521.T

ISIN

JP3207000005

As of Oct 1, 2024, Kaken Pharmaceutical Co's P/S ratio stood at 1.98, a 10% change from the 1.8 P/S ratio recorded in the previous year.

The Kaken Pharmaceutical Co P/S history

Kaken Pharmaceutical Co Aktienanalyse

What does Kaken Pharmaceutical Co do?

Kaken Pharmaceutical Co Ltd is a Japanese pharmaceutical company based in Tokyo. The company was founded in 1949 and has since grown continuously to establish itself as a flagship of the Japanese pharmaceutical industry. The company specializes in the production and sale of prescription and over-the-counter drugs. However, it has also heavily focused on research and development of new medications to expand its market share. Kaken Pharmaceutical's business model is to develop and manufacture high-quality products to ensure they meet the needs and requirements of customers. This includes a wide range of medications, ranging from pain relievers and antiallergics to cosmetic products. The company categorizes its products into five different categories: dermatology, pediatrics, oncology, gastroenterology, and orthopedics. Each of these categories specializes in treating and preventing various diseases, conditions, and complaints, offering a wide range of products. Dermatology is one of the key divisions of Kaken Pharmaceutical. The company offers medications for treating skin conditions such as psoriasis, eczema, dermatitis, and acne. One of its most well-known products is the anti-acne medication Isotretinoin. It works by reducing sebum production, thus reducing inflammation and pore blockage. Kaken Pharmaceutical's pediatrics products focus on treating children. Syrups and drops for symptom relief of colds, coughs, fevers, and diarrhea are among the products offered. In this category, Kaken Pharmaceutical also provides medications for treating children with ADHD. Oncology medications are offered by Kaken Pharmaceutical under the name "Kaken Pharma." These products are intended for the treatment of cancer diseases such as lung, breast, and stomach cancer. The company is constantly striving to improve its research and development to make cancer treatment more effective and efficient. The gastroenterology category focuses on treating digestive disorders such as heartburn, reflux, and gastric ulcers. Kaken Pharmaceutical has introduced several products, including drugs that inhibit stomach acid, which are offered in the form of tablets and granules. Orthopedic medications from Kaken Pharmaceutical are used to treat pain and inflammation of the skeletal system, such as relieving joint pain, arthritis, and osteoporosis. The most well-known product is the pain reliever Ibuprofen, which is available for both oral and topical use. In conclusion, Kaken Pharmaceutical Co Ltd is a company committed to meeting the medical and cosmetic needs of customers. Each product is carefully developed and manufactured to ensure the highest quality and effectiveness. With its wide range of products and research efforts, the company is an important player in the global pharmaceutical market. Kaken Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Kaken Pharmaceutical Co's P/S Ratio

Kaken Pharmaceutical Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Kaken Pharmaceutical Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Kaken Pharmaceutical Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Kaken Pharmaceutical Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Kaken Pharmaceutical Co stock

What is the price-to-earnings ratio of Kaken Pharmaceutical Co?

The price-earnings ratio of Kaken Pharmaceutical Co is currently 1.98.

How has the price-earnings ratio of Kaken Pharmaceutical Co changed compared to last year?

The price-to-earnings ratio of Kaken Pharmaceutical Co has increased by 10% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Kaken Pharmaceutical Co high compared to other companies?

Yes, the price-to-earnings ratio of Kaken Pharmaceutical Co is high compared to other companies.

How does an increase in the price-earnings ratio of Kaken Pharmaceutical Co affect the company?

An increase in the price-earnings ratio of Kaken Pharmaceutical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Kaken Pharmaceutical Co affect the company?

A decrease in the price-earnings ratio of Kaken Pharmaceutical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Kaken Pharmaceutical Co?

Some factors that influence the price-earnings ratio of Kaken Pharmaceutical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Kaken Pharmaceutical Co pay?

Over the past 12 months, Kaken Pharmaceutical Co paid a dividend of 150 JPY . This corresponds to a dividend yield of about 3.92 %. For the coming 12 months, Kaken Pharmaceutical Co is expected to pay a dividend of 155.09 JPY.

What is the dividend yield of Kaken Pharmaceutical Co?

The current dividend yield of Kaken Pharmaceutical Co is 3.92 %.

When does Kaken Pharmaceutical Co pay dividends?

Kaken Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kaken Pharmaceutical Co?

Kaken Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kaken Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 155.09 JPY are expected. This corresponds to a dividend yield of 4.06 %.

In which sector is Kaken Pharmaceutical Co located?

Kaken Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kaken Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kaken Pharmaceutical Co from 12/1/2024 amounting to 75 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kaken Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kaken Pharmaceutical Co in the year 2023?

In the year 2023, Kaken Pharmaceutical Co distributed 150 JPY as dividends.

In which currency does Kaken Pharmaceutical Co pay out the dividend?

The dividends of Kaken Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kaken Pharmaceutical Co

Our stock analysis for Kaken Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kaken Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.